Preparation and purification of an end to end coupled mEGF-dextran conjugate

Bioconjugate Chemistry

Volumn 8, Issue 6, 1997, Pages 927-934

  Zhao, Qinghai ^a   Gottschalk, Ingo ^a   Carlsson, Jörgen ^a   Arvidsson, Lars Erik ^d   Oscarsson, Sven ^b   Medin, Anders ^c   Ersson, Bo ^c   Janson, Jan Christer ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MÄLARDALEN UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHORESIS; ION EXCHANGE; SODIUM CHLORIDE; UREA;

AMINO TERMINUS; COUPLING EFFICIENCY; END TO END; END-COUPLED; EPIDERMAL GROWTH FACTORS; GEL-FILTRATION; NON-CHARGED DEXTRANS; POLYACRYLAMIDE GEL ELECTROPHORESIS; REDUCTIVE AMINATION; SEPHADEX;

DEXTRAN;

ANIMALIA;

EID: 0031281982     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970173m     Document Type: Article

References (48)

1. Andersson, A., Holmberg, A, Carlsson, J., Carlsson, J., Pontén, J., and Westermark, B. (1991) Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Int. J. Cancer 47, 439-444.
2. Andersson, A., Capala, J., and Carlsson, J. (1992) Effects of EGF-dextran-tyrosine-131-I conjugates on clonogenic survival of cultured glioma cells. J. Neuro-Oncol. 14, 213-223.
3. Bigner, S. H., Burger, P. C., Wong, A. J., Werner, M. H., Hamilton, S. R., Muhlbalier, L. H., Vogelstein, B., and Bigner, D. D. (1988) Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J. Neuropathol. Exp. Neurol. 47, 191-205.
4. Blomhoff, H. K., Blomhoff, R., and Christensen, T. B. (1983) Enhanced stability of β-galactosidase in parenchymal and nonparenchymal liver cells by conjugation with dextran. Biochim. Biophys. Acta 757 (2), 202-208.
5. Borch, R. F., Bernstein, M. D., and Dust, H. D. (1971) The cyanohydridoborate anion as a selective reducing agent. J. Am. Chem. Soc. 93, 2897-2903.
6. Carlsson, J., Gedda, L., Grönvik, C., Hartman, T., Lindström, A., Lindström, P., Lundqvist, H., Lövqvist, A., Malmqvist, J., Olsson, P., Essand, M., PontÇn, J., Sjöberg, S., and Westermark, B. (1994) Strategy for boron neutron capture therapy against tumor cells with overexpression of the epidermal growth factor-receptor. Int. J. Radiat., Oncol., Biol,. Phys. 30 (1), 105-115.
7. Carpenter, G. (1987) Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56, 881-914.
8. Carpenter, G., and Cohen, S. (1976) 125-I labeled human growth factor. J. Cell Biol. 71, 159-171.
9. Carpenter, G., and Cohen, S. (1979) Epidermal growth factor. Annu. Rev. Biochem. 48, 193-216.
10. Chabot, J. G., Walker, P., and Pelletier, G. (1986) Distribution of epidermal growth factor binding sites in the adult rat liver. Am. J. Physiol. 250, G760-G764.
11. DeBelder, A. N. (1990) Dextran, 2nd ed., Pharmacia Print, Uppsala, Sweden.
12. Dubois, M., Gilles, K. A., Hamilton, P. A., Rebers, P. A., and Smith, F. (1956) Colorimetric method for determination of sugars and related substances. Ann. Biochem. 28, 350-356.
13. Dunn, W. A., Connolly, T. P., and Hubbard, A. L. (1986) Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway. J. Cell Biol. 102, 24-36.
14. Emmrich, P., Baumann, W., and Stechele, U. (1977) Studies on the kinetics and renal excretion of low and high molecular weight dextrans in preterm babies, newborns and young infants. Eur. J. Pediatr. 125, 181-190.
15. Fassio, E., Terg, R., Landeira, G., Abecasis, R., Salemne, M., Podesta, A., Rodriguez, P., Levi, D., and Kravetz, D. (1992) Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J. Hepatol. 14, 310-316.
16. Filmus, J., Pollak, M. N., Cailleau, R., and Buick, R. N. (1985) MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptor, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. 128, 898-905.
17. Fudui, K., Moriyama, T., Miyake, Y., Mizutani, K., and Tanaka, O. (1982) Purification and properties of glucosyltransferase responsible for water-insoluble glucan synthesis from Streptococcus mutans. Infect. Immun. 37 (1), 1-9.
18. Gedda, L., Olsson, P., Pontén, J., and Carlsson, J. (1996) Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Bioconjugate Chem. 7, 584-591.
19. Holmberg, A., and Meurling, L. (1993) Preparation of Sulfhydrylborane-dextran conjugates for boron neutron capture therapy. Bioconjugate Chem. 4, 570-573.
20. Holmberg, A., Silen, Å., Marquez, M., Bergwall, P., Westlin, J., and Nilsson, S. (1994) An alternative methods of labelling antibodies with 99mTc. Antibody, Immunoconjugates, Radiophar,. 7, 149-154.
21. Kato, A., Sasaki, Y., Furuta., R., and Kobayashi, K. (1990) Functional protein-polysacchride conjugate prepared by controlled dry-heating of ovalbumin-dextran mixtures. Agric. Biol. Chem. 54 (1), 107-112.
22. Klotz, U., and Kroemer, H. (1987) Clinical pharmacokinetic considerations in the use of plasma expanders. Clin. Pharmacokinet. 12, 123-135.
23. Lane, C. F. (1975) Sodium cyanoborohydride - a highly selective reducing agent for organic functional groups. Synthesis, March, 135-145.
24. Libermann, T. A., Razon, N., Bartal, A. D., Yarden, Y., Schlessinger, J., and Scoreq, H. (1984) Expression of epidermal growth factor receptors in human brain tumors. Cancer Res. 44, 753-760.
25. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature (London) 313, 144-147.
26. Lindström, A., Lundqvist, H., and Carlsson, J. (1993) Distribution of 125-I after administration of 125-I-labeled epidermal growth factor-dextran conjugates in mice. In Annelie Lindström thesis, Targeting to EGF receptors. Preparation of EGF-dextran conjugates and analysis of their metabolism in vitro and in vivo. Acta Univ. Upsaliensis 428.
27. Lövqvist, A., Lindström, A., and Carlsson, J. (1993) Binding, internalization and excretion of TGFa-dextran associated radioactivity in cultured human glioma cells. Cancer Biother. 8, 345-356.
28. Lundblad, R. L., and Noages, C. M. (1984) Chemical Reagents for Protein Modification, pp 147-162, CRC Press, Boca Raton, FL.
29. Marshall, J. J. (1978) Manipulation of the properties of enzymes by covalent attachment of carbohydrate. Trends Biochem. 3, 79-83.
30. Melton, R. G., Wiblin, C. N., Foster, R. L., and Sherwood, R. F. (1987) Covalent linkage of carboxypeptidase G2 to soluble dextrans. I. Properties of conjugates and effects on plasma persistence in mice. Biochem. Pharmacol. 36, 105-112.
31. Mendelsohn, J. (1988) Growth factor receptors as targets for antimor therapy with monoclonal antibodies. Monoclon. Antibody Ther. 45, 147-160.
32. Messing, E. M., and Rezinkoff, C. A. (1992) Epidermal growth factor and its receptor: markers of - and targets for - chemo-prevention of bladder cancer. J. Cell. Biochem. Suppl. 161, 56-62.
33. Moon, P. F., Snyder, J. R., Haskins, S. C., Perron, P. R., and Kramer, G. C. (1991) Effects of highly concentrated hypertonic saline-dextran volume expander on cardiopumonary function in anesthetized normovolemic horses. Am. J. Vet. Res. 52, 1611-1618.
34. Murakami, T., Misaki, M., Masuda, S., Higashi, Y., Fuwa, T., and Yata, N. (1994) Dose-dependent plasma clearance of human epidermal growth factor in rats. J. Pharm. Sci. 83, 1400-1403.
35. Nistér, M., Wedell, B., Bestsholtz, C., Bywater, M., Pettersson, M., Westermark, B., and Mark, J. (1987) Evidence for professional changes in the human maligan glioma line U-343Ga: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived groth factor. Cancer Res. 47, 4953-4960.
36. Olsson, P., Lindström, A., and Carlsson, J. (1994) Internalization and excretion of epidermal growth factor-dextran associated radioactivity in cultured human squamous-carcinoma cells. Int. J. Cancer 56, 529-537.
37. Ozawa, S., Ueda, M., Ando, N., Abe, O., Minoshima, S., and Shimizu, N. (1989) Selective killing of squamous carcinoma cells by an immunotoxin that recognise the EGF receptor. Int. J. Cancer 43, 152-157.
38. Sauter, G., Haley, J., Chew, K., Kerschmann, R., Moore, D., Carroll, P., Moch, H., Gudat, F., Mihatsch, M. J., and Waldman, F. (1994) Epidermal-growth-factor-receptor expression is associated with rapid tumour proliferation in bladder cancer. Int. J. Cancer 57 (4), 508-514.
39. Seppala, I., and Makela, O. (1989) Antigencity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. J. Immunol. 143 (4), 1259-1264.
40. Siegall, C. B., Fitzgerald, D. J., and Pastan, I. (1990) Selective killing of tumor cells using EGF-or TGF-alpha-pseudomonas exotoxin chimeric molecules. Semin. Cancer Biol. 1 (15), 345-350.
41. Sjöström, A., Bue, P., Malmström, P. U., Nilsson, S., and Carlsson, J. (1997) Binding, internalisation and degradation of EGF-dextran conjugates in two human bladder cancer cell lines. Int. J. Cancer 70, 383-389.
42. Soley, M., and Hollenberg, M. D. (1987) Epidermal growth factor (urogastrone)-stimulated gluconeogenesis in isolated mouse hepatocytes. Arch. Biochem. Biophys. 255, 136-146.
43. Srivastava, R. A. (1991) Effect of glycosylation of bacterialamy-lase on stability and active site conformation. Indian J. Biochem. Biophys. 28 (2), 109-113.
44. Todderud, G., and Carpenter, G. (1989) Epidermal growth factor: the receptor and its function. Biofactors 2, 11-15.
45. Werner, M. H., Humphrey, P. A., Bigner, D. D., and Bigner, S. H. (1988) Growth effects of epidermal growth factor (EGF) and monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol. 77, 196-201.
46. Westermark, B., Magnusson, A., and Heldin, C. H. (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J. Neurosci. Res. 8, 491-507.
47. Yalpani, M., and Brooks, D. E. (1985) Selective chemical modifications of dextran. J. Polym. Sci. 23, 1395-1405.
48. Yasuda, Y., Fujita, T., Tadakura, Y., Hashida, M., and Sezaki, H. (1990) Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol. Chem. Pharm. Bull. Tokyo. 38 (7), 5053-5056.